Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Food and Drug Analysis
|
December 12, 2024
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Ya-Chu Tang, Yung-Jen Chuang, Hsin-Huei Chang, et al.
Journal of Food and Drug Analysis
|
June 1, 2022
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
Ya-Chu Tang, Hsin-Huei Chang, Huang-Hui Chen, et al.
Endocrinology
|
January 16, 2014
Endothelin-1 stimulates resistin gene expression
Ya-Chu Tang, Chi-Wei Liu, Hsin-Huei Chang, et al.
Oncotarget
|
August 29, 2015
LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation
Chia-Huei Lee, Kao-Lu Pan, Ya-Chu Tang, et al.
General and Comparative Endocrinology
|
July 7, 2012
Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes
Hsin-Huei Chang, Yao-Ming Huang, Chi-Peng Wu, et al.
Free Radical Biology & Medicine
|
October 30, 2017
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells
Huang-Hui Chen, Hsin-Huei Chang, Jang-Yang Chang, et al.
Theranostics
|
April 16, 2021
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Ya-Chu Tang, Jenn-Ren Hsiao, Shih-Sheng Jiang, et al.
Journal of Cellular Physiology
|
September 11, 2014
IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer
Chia-Huei Lee, Jeffrey Shu-Ming Chang, Shih-Han Syu, et al.
Pharmacological Research
|
December 21, 2024
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
Ya-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, et al.
Journal of Medicinal Chemistry
|
November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization
Hsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Food and Drug Analysis
|
December 12, 2024
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Ya-Chu Tang, Yung-Jen Chuang, Hsin-Huei Chang, et al.
Journal of Food and Drug Analysis
|
June 1, 2022
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
Ya-Chu Tang, Hsin-Huei Chang, Huang-Hui Chen, et al.
Endocrinology
|
January 16, 2014
Endothelin-1 stimulates resistin gene expression
Ya-Chu Tang, Chi-Wei Liu, Hsin-Huei Chang, et al.
Oncotarget
|
August 29, 2015
LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation
Chia-Huei Lee, Kao-Lu Pan, Ya-Chu Tang, et al.
General and Comparative Endocrinology
|
July 7, 2012
Endothelin-1 stimulates suppressor of cytokine signaling-3 gene expression in adipocytes
Hsin-Huei Chang, Yao-Ming Huang, Chi-Peng Wu, et al.
Free Radical Biology & Medicine
|
October 30, 2017
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells
Huang-Hui Chen, Hsin-Huei Chang, Jang-Yang Chang, et al.
Theranostics
|
April 16, 2021
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Ya-Chu Tang, Jenn-Ren Hsiao, Shih-Sheng Jiang, et al.
Journal of Cellular Physiology
|
September 11, 2014
IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer
Chia-Huei Lee, Jeffrey Shu-Ming Chang, Shih-Han Syu, et al.
Pharmacological Research
|
December 21, 2024
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
Ya-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, et al.
Journal of Medicinal Chemistry
|
November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization
Hsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.
Page
of 2